Evidence map›Paper›PMID 23334952›Full record

ArticleInternational immunology2013

B-Raf is required for positive selection and survival of DP cells, but not for negative selection of SP cells.

Tara J Dillon, Maho Takahashi, Yanping Li, Srilatha Tavisala, Susan E Murray, Amy E Moran, David C Parker, Philip J S Stork

Open access · hybridAbstract read
In one paragraph

Article in International immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tara J DillonVollum Institute, Oregon Health and Science University, Portland, OR, USA.
Maho Takahashi
Yanping Li
Srilatha Tavisala
Susan E Murray
Amy E Moran
David C Parker
Philip J S Stork
Oregon Health & Science University · USVollum Institute · USProvidence Portland Medical Center · US

Funding

The non-canonical NF-kappaB pathway in survival and function of T lymphocytesR01AI092080 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI PARKER, DAVID C · 2011 to 2015
$1.9M
NIAID NIH HHS R01 AI092080PHS HHS GHRCO-0014PHS HHS GVOLL0230
6 · The paper itself

Abstract

The duration of signaling through the MAP kinase (or ERK pathway) cascade has been implicated in thymic development, particularly positive and negative selection. In T cells, two isoforms of the MAP kinase kinase kinase Raf function to transmit signals from the T-cell receptor to ERK: C-Raf and B-Raf. In this study, we conditionally ablated B-Raf expression within thymocytes to assess the effects on ERK activation and thymocyte development. The complete loss of B-Raf is accompanied by a dramatic loss of ERK activation in both the double positive (DP) and single positive (SP) thymocytes, as well as peripheral splenocytes. There was a significant decrease in the cellularity of KO thymi, largely due to a loss of pre-selected DP cells, a decrease in DP cells undergoing positive selection, and a defect in SP maturation. B-Raf plays significant roles in survival of DP thymocytes and function of SP cells in the periphery. Surprisingly, we saw no effect of B-Raf deficiency on negative selection of autoreactive SP thymocytes, despite the greatly reduced ERK activation in these cells.

Indexed as

AnimalsCD4 AntigensCD8 AntigensCell DifferentiationCells, CulturedCell SurvivalClonal DeletionEnzyme ActivationExtracellular Signal-Regulated MAP KinasesMAP Kinase Signaling SystemMiceMice, Inbred C57BLMice, KnockoutProto-Oncogene Proteins B-rafReceptors, Antigen, T-CellThymus GlandCD4 AntigensCD8 AntigensExtracellular Signal-Regulated MAP KinasesProto-Oncogene Proteins B-rafReceptors, Antigen, T-Cell

Identifiers

PMID23334952
PMCPMC3597848
OpenAlexW2147124948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.